Filing Details

Accession Number:
0000891293-15-000048
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-01 18:21:54
Reporting Period:
2015-09-29
Filing Date:
2015-10-01
Accepted Time:
2015-10-01 18:21:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cti Biopharma Corp CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204264 W Jack Singer 3101 Western Ave
Suite 600
Seattle WA 98121
Evp, Global Medical Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-29 5,600 $1.38 1,446,250 No 4 S Direct
Common Stock Disposition 2015-09-29 7,300 $1.39 1,438,950 No 4 S Direct
Common Stock Disposition 2015-09-29 15,083 $1.40 1,423,867 No 4 S Direct
Common Stock Disposition 2015-09-29 9,263 $1.41 1,414,604 No 4 S Direct
Common Stock Disposition 2015-09-29 28,254 $1.41 1,386,350 No 4 S Direct
Common Stock Disposition 2015-09-29 250 $1.42 1,386,100 No 4 S Direct
Common Stock Disposition 2015-09-29 6,094 $1.42 1,380,006 No 4 S Direct
Common Stock Disposition 2015-09-29 3,156 $1.43 1,376,850 No 4 S Direct
Common Stock Disposition 2015-09-30 5,115 $1.45 1,371,735 No 4 S Direct
Common Stock Disposition 2015-09-30 751 $1.45 1,370,984 No 4 S Direct
Common Stock Disposition 2015-09-30 100 $1.46 1,370,884 No 4 S Direct
Common Stock Disposition 2015-09-30 19,034 $1.46 1,351,850 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct